Description
Omnicef 250mg Injection is a third-generation cephalosporin antibiotic containing Cefotaxime. It is used to treat mild to moderate bacterial infections. Cefotaxime works by inhibiting bacterial cell wall synthesis, leading to bacterial death. This injection is NPPA regulated and administered under medical supervision.
The 250mg dose is commonly used in children or patients requiring lower antibiotic doses.
Uses
-
Respiratory tract infections – bronchitis, pneumonia, sinusitis, tonsillitis
-
Urinary tract infections (UTIs)
-
Skin and soft tissue infections
-
Bone and joint infections
-
Intra-abdominal infections (peritonitis, post-surgical infections)
-
Septicemia (bloodstream infections)
-
Meningitis (in certain pediatric cases)
-
Other mild to moderate bacterial infections
How It Works
Cefotaxime binds to penicillin-binding proteins (PBPs) in bacterial cell walls, preventing their formation. This weakens the bacterial cell wall and causes bacterial death, effectively treating infections.
Side Effects
Common:
-
Pain, redness, or swelling at injection site
-
Nausea, vomiting, diarrhea
-
Mild rash, headache, or fever
Serious (rare):
-
Severe allergic reactions (anaphylaxis, swelling, difficulty breathing)
-
Blood disorders (low platelets, anemia, leukopenia)
-
Liver enzyme elevation or jaundice
-
Clostridium difficile-associated diarrhea
Precautions
-
Avoid in patients allergic to cephalosporins or penicillins
-
Use with caution in renal or hepatic impairment (dose adjustment may be necessary)
-
Not recommended for neonates with hyperbilirubinemia
-
Use in pregnancy and breastfeeding only if prescribed by a doctor
Administration
-
Given via intravenous (IV) or intramuscular (IM) injection
-
Dosage depends on age, weight, and severity of infection
-
The 250mg dose is commonly prescribed for pediatric patients or low-dose requirements
Leave a Reply